USPTO Examiner SWANSON LEAH JENNINGS - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19255001SAFETY SYRINGEJune 2025February 2026Allow820YesNo
19004370PRE-FILLED SYRINGE SAFETY DEVICES AND INJECTORS, SYSTEMS, AND METHODS OF USEDecember 2024August 2025Allow720YesYes
18596067OPHTHALMIC DEVICEMarch 2024March 2026Allow2420YesNo
18513903INTERNAL BALLOON SHEATHNovember 2023March 2026Allow2830NoNo
18493552VASCULAR ACCESS DEVICES WITH INTEGRATED SAFETY FEATURESOctober 2023November 2024Abandon1310NoNo
18485168ASPIRATION CATHETER SYSTEMS AND METHODS OF USEOctober 2023September 2025Allow2320YesYes
18285671PRE-FILLED SYRINGE SAFETY DEVICES AND INJECTORS, SYSTEMS, AND METHODS OF USEOctober 2023December 2024Allow1420YesNo
18369325Cartilage repair, preservation and growth by stimulation of bone-chondral interface and delivery system and methods thereforSeptember 2023November 2025Abandon2620NoNo
18243008MEDICAMENT DELIVERY DEVICESeptember 2023July 2025Allow2320YesNo
18242899Injector and Injection Method ThereforSeptember 2023May 2024Allow911YesNo
18453423CATHETER ASSEMBLY WITH GUIDEWIRE, CATHETER AND PUNCTURE NEEDLEAugust 2023March 2025Allow1920YesNo
18365024OCULAR INJECTOR AND METHODS FOR ACCESSING SUPRACHOROIDAL SPACE OF THE EYEAugust 2023December 2023Allow410YesNo
18222841MEDICAMENT DELIVERY DEVICEJuly 2023October 2025Allow2730YesNo
18342443INFUSION TUBE SYSTEM AND METHOD FOR MANUFACTUREJune 2023August 2024Allow1410YesNo
18206515OCCLUSION DETECTION DEVICES, SYSTEMS, AND METHODSJune 2023January 2026Allow3130YesNo
18143844APPARATUS AND METHODS FOR DELIVERING THERAPEUTIC AGENTSMay 2023May 2025Abandon2530YesNo
18309173ASPIRATION CATHETER SYSTEMS AND METHODS OF USEApril 2023April 2025Allow2320YesNo
18297429ASPIRATION CATHETER SYSTEMS AND METHODS OF USEApril 2023November 2023Allow710YesNo
18127406INFUSION TUBE SYSTEM AND METHOD FOR MANUFACTUREMarch 2023November 2024Abandon2010YesNo
18185710ASPIRATION CATHETER SYSTEMS AND METHODS OF USEMarch 2023March 2026Allow3610YesNo
18023407MULTI-STAGE INJECTION DEVICEFebruary 2023February 2026Allow3600NoNo
18109507Wearable Injector With Sterility SensorsFebruary 2023June 2025Allow2811YesNo
18100845SYSTEMS AND METHODS FOR ANCHORING MEDICAL DEVICESJanuary 2023March 2024Allow1410YesNo
18156891DEVICES AND METHODS FOR ELECTROTRANSFERJanuary 2023January 2024Abandon1210NoNo
17875031Drug Delivery Assembly Including An ActuatorJuly 2022November 2024Allow2730YesNo
17869202INTERNAL BALLOON SHEATHJuly 2022August 2023Allow1310YesNo
17747566OPHTHALMIC DEVICEMay 2022November 2023Allow1820NoNo
17739816Spacer Assembly for Drug Delivery DeviceMay 2022October 2024Allow2931NoNo
17662041HUMIDIFICATION APPARATUS HAVING RFID TAG SENSOR AT PATIENT END OF GAS PATHWAYMay 2022October 2025Abandon4140YesYes
17773309VASCULAR RE-ENTRY CATHETERApril 2022November 2025Abandon4351NoNo
17730308EXTENSION TUBE CLAMP PROVIDING POSITIVE DISPLACEMENTApril 2022July 2023Allow1510YesNo
17711495OCULAR INJECTOR AND METHODS FOR ACCESSING SUPRACHOROIDAL SPACE OF THE EYEApril 2022June 2023Allow1430YesNo
17683580SAFETY SYRINGEMarch 2022February 2025Abandon3510NoNo
17681768Cartilage repair, preservation and growth by stimulation of bone-chondral interface and delivery system and methods thereforFebruary 2022May 2023Allow1410NoNo
17578749APPARATUS AND METHODS FOR BIOMIMETIC EXPRESSION OF BREAST MILKJanuary 2022March 2024Allow2630YesNo
17566079SYRINGE-BASED MICROBUBBLE GENERATOR WITH AN AERATORDecember 2021March 2022Allow300YesNo
17549120AUTO-INJECTION DEVICEDecember 2021September 2023Abandon2110NoNo
17542386SYRINGE-BASED MICROBUBBLE GENERATORDecember 2021August 2023Allow2010YesNo
17518139MEDICAMENT DELIVERY DEVICENovember 2021October 2023Allow2320YesNo
17452523APPARATUS AND PROCESS FOR PRODUCING CO2 ENRICHED MEDICAL FOAMOctober 2021July 2023Allow2110YesNo
17508246DUAL CANNULATED SUCTION AND DELIVERY DEVICEOctober 2021December 2025Abandon5020NoNo
17481435CATHETER DELIVERY GUIDEWIRE CLAMPSeptember 2021May 2023Allow1940YesYes
17468556MEDICAL DEVICESeptember 2021December 2025Abandon5120NoNo
17398535INFUSION TUBE SYSTEM AND METHOD FOR MANUFACTUREAugust 2021February 2023Allow1810YesNo
17381950OPHTHALMIC DEVICEJuly 2021March 2022Allow810NoNo
17421661Injection DeviceJuly 2021June 2025Allow4710YesNo
17299850DEVICES AND PROCESSES FOR DELIVERY OF THERAPEUTIC FLUIDSJune 2021June 2025Allow4810YesNo
17329408METHODS FOR OPERATING MODE TRANSITIONS AND RELATED INFUSION DEVICES AND SYSTEMSMay 2021December 2022Allow1800NoNo
17323382MEDICAMENT DELIVERY DEVICEMay 2021October 2023Allow2920YesNo
17314412CATHETER ASSEMBLY WITH GUIDEWIRE, CATHETER AND PUNCTURE NEEDLEMay 2021March 2023Allow2210YesNo
17233190CAP ASSEMBLY FOR A MEDICAMENT DELIVERY DEVICEApril 2021March 2026Allow5950NoNo
17231025CONTAINER AND DIALYSIS MACHINE COMPRISING A CONTAINERApril 2021November 2024Abandon4320NoNo
17208955ENDOSCOPIC CANNULAMarch 2021May 2025Allow5020YesNo
17209167Tubular Structures with Variable SupportMarch 2021August 2021Allow410YesNo
17277704NASOGASTRIC PROBEMarch 2021June 2025Abandon5110NoNo
17195230VASCULAR INSTRUMENT DELIVERY DEVICE AND RELATED SYSTEMS AND METHODSMarch 2021July 2025Allow5250YesNo
17180105Wearable Injector with Sterility SensorsFebruary 2021November 2022Allow2141YesNo
17180578DRUG DELIVERY ASSEMBLY INCLUDING A REMOVABLE CARTRIDGEFebruary 2021August 2021Allow620YesNo
17179188FLEXIBLE TIP CATHETERFebruary 2021November 2022Allow2000YesNo
17173389HEMOSTATIC DEVICES AND METHODS OF USEFebruary 2021May 2024Allow3940YesNo
17264256Implantable Port Placement System Including Low-Scarring ExteriorJanuary 2021November 2025Allow5850YesNo
17158396SYRINGE-BASED MICROBUBBLE GENERATORJanuary 2021September 2021Allow720YesNo
17144914Oral Mucosal Electroporation Device and Use ThereofJanuary 2021June 2024Allow4130YesNo
17126295SYSTEMS AND METHODS FOR ANCHORING MEDICAL DEVICESDecember 2020October 2022Allow2200YesNo
17247395INTRAVASCULAR CATHETER INSERTION DEVICEDecember 2020November 2023Allow3600YesNo
17114238MEDICAMENT DELIVERY DEVICEDecember 2020August 2023Allow3220YesNo
17114235MEDICAMENT DELIVERY DEVICEDecember 2020September 2024Allow4550YesNo
17114241MEDICAMENT DELIVERY DEVICEDecember 2020August 2023Allow3220YesNo
15734773AN ENTERAL FEEDING DEVICEDecember 2020August 2024Allow4420YesNo
17055905QUICK RELEASE CAPSULESNovember 2020April 2025Abandon5321NoNo
17096845SYNERGISTIC FEATURES AND FUNCTIONS RELATED TO OPERATION OF A MEDICATION DELIVERY SYSTEM AND A MEAL TRANSACTION APPLICATIONNovember 2020November 2024Allow4850YesNo
17090236AUTO-INJECTION DEVICENovember 2020September 2021Allow1030YesNo
17048260SYRINGEOctober 2020December 2023Abandon3810NoNo
17042144FAT SUCTION AND GRAFT SYRINGE HAVING NEGATIVE PRESSURE ADJUSTMENT MEANSSeptember 2020October 2022Allow2510YesNo
17032715GASKET PRESSING TOOL AND DRUG ADMINISTRATION TOOL USING THE SAMESeptember 2020March 2025Allow5421NoNo
17040431DEVICE FOR ADMINISTERING A FLUIDSeptember 2020June 2024Abandon4520NoNo
17022936Steerable Medical Device HandleSeptember 2020March 2025Allow5440YesNo
16969691CONTROLLED DISPENSE SYRINGEAugust 2020April 2023Allow3220YesNo
16993062CATHETER ADAPTERSAugust 2020May 2023Allow3330YesNo
16932135HYPODERMIC DEVICE WITH AN ARRAY OF HYPODERMIC NEEDLESJuly 2020January 2023Abandon3040YesYes
16929081CLOSED-LOOP GLUCOSE AND/OR INSULIN CONTROL SYSTEMJuly 2020April 2023Abandon3310NoNo
16910640DEVICES AND METHODS FOR DELIVERING A LYOPHILIZED MEDICAMENTJune 2020January 2024Allow4320YesNo
16905382STIMULATION OF CARTILAGE FORMATION USING REDUCED PRESSURE TREATMENTJune 2020September 2022Allow2710NoNo
16898905PRESSURE CONTROL IN PHACOEMULSIFICATION SYSTEMJune 2020September 2022Allow2710NoNo
16898529WEARABLE AUTOMATED MEDICATION DELIVERY SYSTEMJune 2020April 2023Allow3420NoNo
16771084INJECTION DEVICE WITH A REMOTE CONTROLJune 2020November 2022Allow2910YesNo
16892100INFUSION PUMP SYSTEM AND METHODSJune 2020January 2023Abandon3170YesNo
16890962ASPIRATION CATHETER SYSTEMS AND METHODS OF USEJune 2020September 2025Abandon6020YesYes
16764638MEDICAL DELIVERY DEVICE WITH AXIALLY EXPANDABLE DRIVE RIBBONMay 2020August 2023Allow3910YesNo
16862448Cartilage repair, preservation and growth by stimulation of bone-chondral interface and delivery system and methods thereforApril 2020December 2021Allow1920YesNo
16858686CONTAINER ADAPTER FOR REMOVABLY ATTACHABLE SYRINGEApril 2020May 2021Allow1330YesNo
16849111SAFETY SYRINGEApril 2020November 2021Allow1900NoNo
16841398OCCLUSION DETECTION DEVICES, SYSTEMS, AND METHODSApril 2020February 2023Allow3540YesNo
16652082TEMPER EVIDENT INJECTOR LOCK AND A LOCKING METHODMarch 2020May 2022Abandon2510NoNo
16800177MEDICAMENT DELIVERY DEVICEFebruary 2020February 2022Allow2310YesNo
16793948EXTENSION TUBE CLAMP PROVIDING POSITIVE DISPLACEMENTFebruary 2020January 2022Allow2310YesNo
16785400SYSTEMS AND METHODS FOR ESTABLISHING A NERVE BLOCKFebruary 2020November 2021Allow2110YesNo
16636168INJECTOR PREMATURE ACTIVATION BLOCKING MECHANISMFebruary 2020April 2022Allow2710YesNo
16774213INTERNAL BALLOON SHEATHJanuary 2020April 2022Allow2730YesNo
16629820MULTI-NEEDLE MODULE SUITABLE FOR SKIN PROCEDURE AT SLOPEJanuary 2020February 2022Abandon2610NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SWANSON, LEAH JENNINGS.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
8
Examiner Affirmed
7
(87.5%)
Examiner Reversed
1
(12.5%)
Reversal Percentile
25.3%
Lower than average

What This Means

With a 12.5% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
31
Allowed After Appeal Filing
6
(19.4%)
Not Allowed After Appeal Filing
25
(80.6%)
Filing Benefit Percentile
24.0%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 19.4% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner SWANSON, LEAH JENNINGS - Prosecution Strategy Guide

Executive Summary

Examiner SWANSON, LEAH JENNINGS works in Art Unit 3783 and has examined 288 patent applications in our dataset. With an allowance rate of 67.4%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 38 months.

Allowance Patterns

Examiner SWANSON, LEAH JENNINGS's allowance rate of 67.4% places them in the 29% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by SWANSON, LEAH JENNINGS receive 2.98 office actions before reaching final disposition. This places the examiner in the 86% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by SWANSON, LEAH JENNINGS is 38 months. This places the examiner in the 31% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +37.0% benefit to allowance rate for applications examined by SWANSON, LEAH JENNINGS. This interview benefit is in the 85% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 20.1% of applications are subsequently allowed. This success rate is in the 22% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 21.9% of cases where such amendments are filed. This entry rate is in the 28% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 46.2% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 42% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 63.6% of appeals filed. This is in the 43% percentile among all examiners. Of these withdrawals, 42.9% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 45.6% are granted (fully or in part). This grant rate is in the 39% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 47% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.